Your browser doesn't support javascript.
loading
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse.
Samra, Bachar; Khoury, Joseph D; Morita, Kiyomi; Ravandi, Farhad; Richard-Carpentier, Guillaume; Short, Nicholas J; El Hussein, Siba; Thompson, Philip; Jain, Nitin; Kantarjian, Hagop; Jabbour, Elias.
Afiliação
  • Samra B; Department of Leukemia and.
  • Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Morita K; Department of Leukemia and.
  • Ravandi F; Department of Leukemia and.
  • Richard-Carpentier G; Department of Leukemia and.
  • Short NJ; Department of Leukemia and.
  • El Hussein S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Thompson P; Department of Leukemia and.
  • Jain N; Department of Leukemia and.
  • Kantarjian H; Department of Leukemia and.
  • Jabbour E; Department of Leukemia and.
Blood Adv ; 5(20): 3913-3918, 2021 10 26.
Article em En | MEDLINE | ID: mdl-34464974
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article